Los Angeles Capital Management
PACB icon

Los Angeles Capital Management’s Pacific Biosciences PACB Stock Holding History

Los Angeles Capital Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,590
Closed -$6.96K – 2548
2025
Q4 		$6.96K Buy
+3,590
New +$6.9K ﹤0.01% 2209
2024
Q2 		– Sell
-16,359
Closed -$61.3K – 1255
2024
Q1 		$61.3K Hold
16,359
– – ﹤0.01% 1121
2023
Q4 		$160K Hold
16,359
– – ﹤0.01% 1109
2023
Q3 		$137K Buy
16,359
+812
+5% +$9.28K ﹤0.01% 1081
2023
Q2 		$207K Buy
+15,547
New +$189K ﹤0.01% 1113
2022
Q4 		– Sell
-27,526
Closed -$160K – 1255
2022
Q3 		$160K Buy
27,526
+55
+0.2% +$316 ﹤0.01% 1186
2022
Q2 		$121K Buy
27,471
+5,410
+25% +$32.9K ﹤0.01% 1284
2022
Q1 		$201K Hold
22,061
– – ﹤0.01% 1360
2021
Q4 		$451K Sell
22,061
-614
-3% -$14.8K ﹤0.01% 1057
2021
Q3 		$579K Hold
22,675
– – ﹤0.01% 984
2021
Q2 		$793K Sell
22,675
-4,560
-17% -$133K ﹤0.01% 954
2021
Q1 		$907K Sell
27,235
-14,875
-35% -$521K ﹤0.01% 939
2020
Q4 		$1.09M Sell
42,110
-175,170
-81% -$2.98M ﹤0.01% 904
2020
Q3 		$2.15M Sell
217,280
-23,579
-10% -$136K 0.01% 546
2020
Q2 		$831K Buy
+240,859
New +$820K ﹤0.01% 918
2014
Q2 		– Sell
-72,060
Closed -$386K – 1268
2014
Q1 		$386K Buy
+72,060
New +$455K ﹤0.01% 973

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Los Angeles Capital Management's PACB Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Pacific Biosciences (PACB) in Q1 2026, closing a stake of 3,590 shares — an estimated $6.96K sold.

Los Angeles Capital Management first reported a position in PACB in Q1 2014 and held it in 16 quarters. The position peaked at $2.15M in Q3 2020. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Pacific Biosciences position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,590 Pacific Biosciences shares in Q1 2026, an estimated $6.96K.
  • Los Angeles Capital Management first reported a position in Pacific Biosciences in Q1 2014 and held it in 16 quarters.
  • Los Angeles Capital Management's Pacific Biosciences position peaked at $2.15M in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.